Launching the therapy, Dr. Jitendra Singh declared that India has officially begun its decisive march toward a Sickle ...

The CRISPR Cas9 gene editing tool — the genetic scissors that won the 2020 Nobel Prize in Chemistry — is essentially based on ...

In a major leap for Atmanirbhar Bharat and India’s genomic medicine capabilities, the government on Wednesday launched the ...

The world-class, low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great ...

The gene editing solution for Sickle Cell Disease, a chronic, single-gene disorder that causes a debilitating systemic syndrome characterised by chronic anaemia ...

India has launched BIRSA 101, the nation’s first indigenous CRISPR-based gene therapy for Sickle Cell Disease, marking a ...

Vittoria Biotherapeutics, Inc., a clinical-stage immunotherapy company pioneering innovative cell therapies, today announced ...

Why is the Supreme Court opinion on the Presidential Reference regarding the assent to Bills by the Governor important for ...

If the gene therapy treatment is proven to be effective in curing the sickle cell disease, it will initially be made available to people with severe sickle cell disease, maybe with organ damage.

CSIR-IGIB and Serum Institute of India sign a tech transfer pact to develop an indigenous, affordable CRISPR-based ...

Science and Technology Minister Jitendra Singh on Wednesday launched Indias first indigenous CRISPR-based gene therapy for sickle cell disease, which particularly affects the countrys tribal ...

In a landmark moment for Indian science, Union Minister of State (Independent Charge) for Science & Technology Dr Jitendra ...